NPG #14 Part 7 cover: Antimicrobial Stewardship in Hospitals, Introduction 101

Antimicrobial Stewardship in Hospitals: An Introduction (101)

In brief: NPG #14 requires every hospital to have an active antibiotic stewardship programme; in 2023 the Joint Commission aligned its standards with the CDC Core Elements, and by 2023, 96% of US acute care hospitals had implemented all seven elements, up from 41% in 2014 (Joint Commission, 2025). Hospital stewardship programmes improve the quality of antimicrobial use and are associated with lower antimicrobial consumption, resistance and costs (Karanika et al., 2016; Schuts et al., 2016).

Prof. Dr. Mehmet Nurullah Kurutkan, Düzce University, Faculty of Business, Department of Health Management

Abstract. Part 7 closes the series with the requirement that is least framed as “medication safety” in the literature: antimicrobial stewardship. Using 1,040 hospital records (title-based search) from a 4,936-record Web of Science corpus, the chapter defines stewardship, traces it from early antimicrobial management teams to the CDC Core Elements and global consensus checklists, and summarises evidence on prescribing, resistance, cost and clinical outcomes. Only 6% of these records use the term “patient safety”, which shows a gap between the Joint Commission’s framing and the field’s own language. A substantial Turkish ICU literature is also reviewed.

Learning objectives

After completing this chapter, the reader will be able to:

  1. Define antimicrobial stewardship and state the NPG #14 requirement and its alignment with the CDC Core Elements.
  2. Describe the main stewardship interventions: restriction, pre-authorisation, prospective audit and feedback, de-escalation and rapid diagnostics.
  3. Summarise evidence on stewardship effects on prescribing, resistance, costs and patient outcomes.
  4. Explain why stewardship is part of a medication management goal.
  5. Appraise stewardship evidence from low- and middle-income settings, including Türkiye.
  6. Design a stewardship monitoring dashboard for an intensive care unit.

Key concepts: antimicrobial stewardship (AMS), antimicrobial stewardship programme (ASP), CDC Core Elements, prospective audit and feedback, pre-authorisation (restriction), de-escalation, rapid diagnostics, antimicrobial resistance (AMR)

Contents

  • 1. Introduction
  • 2. History and development
  • 3. Definitions and conceptual schema
  • 4. Distinguishing neighbouring concepts
  • 5. Types and classifications
  • 6. Theoretical frameworks and models
  • 7. Themes and bibliometric profile
  • 8. The situation in Türkiye
  • 9. Debates and contradictions in the literature
  • 10. Measurement problems
  • 11. Research gaps and agenda
  • 12. Relevance today and practical implications
  • Summary box, discussion questions, further reading, glossary and references

Method box: how this chapter was produced

ComponentApplication
Source documentJoint Commission (2025), National Performance Goal #14 “Effectively Managing Medications” (formerly part of the National Patient Safety Goals). (Joint Commission, 2025)
Database and indexesWeb of Science Core Collection (SCI-EXPANDED, SSCI, ESCI)
Search strategy (series)Seven component blocks derived from the NPG #14 requirements, a core medication safety block and a hospital context block; combined set #24 = ((#1 AND component blocks 1-4) OR medication reconciliation OR anticoagulant block) AND hospital block, OR the title-based stewardship block; filtered to articles and reviews, English, 2000-2026.
Component query (this chapter)TI=("antimicrobial stewardship" OR "antibiotic stewardship" OR "antimicrobial management program*" OR "antibiotic management program*") AND TI=(hospital* OR inpatient* OR "acute care" OR "intensive care" OR ICU)
Core blockTS=("medication safety" OR "medication error*" OR "medication mistake*" OR "drug error*" OR "prescribing error*" OR "prescription error*" OR "dispensing error*" OR "administration error*" OR "transcription error*" OR "adverse drug event*" OR "preventable adverse drug*" OR "medication-related harm" OR "medication incident*" OR "medication management" OR "medication use process" OR "safe medication" OR "high-alert medication*" OR "wrong drug" OR "wrong dose" OR "wrong route")
Search date and span16 November 2026; publication years 2000-2026 (2027 early-access records retained)
Inclusion and exclusionIncluded: hospital-context records matching this component. Excluded: retracted publications and records whose only labeling match was “open-label”.
Screening countsSeries corpus 4,936; tagged for this component 1,040; excluded 0; eligible 1,040; core evidence set (component term in title or author keywords) 1,040; “patient safety” framed 65.
Evidence extractionDefinitions, milestones, models, measures, debates and gaps were extracted from the abstracts of the most cited and most recent records in the core set.
LimitationsSingle database; English only; component tagging is rule based and reproduces the WoS query on title, abstract and keywords (agreement within 5 records per component); evidence read at abstract level; full texts were not read.
Antimicrobial Stewardship in Hospitals: from the series corpus to the evidence setIdentification: 4,936 recordsWoS Core Collection, set #24, 16 Nov 2026Component tagging: 1,040 recordsComponent query re-applied to TI, AB, AK, KPEligible component subcorpus: 1,04065 also use "patient safety" framingCore evidence set: 1,040 recordsComponent term in title or author keywordsExcluded: 0 recordsRetracted publication or “open-label”match only (label noise)Background layer: 0Match in abstract or Keywords Plus only
Figure 1. Flow of records for Part 7. Counts match the screening sheet of the supplementary workbook. Source: produced by the author from the corpus.

1. Introduction

Antibiotics are the only drugs whose misuse harms future patients as well as the current one. Antimicrobial-resistant infections carry considerable medical and societal costs (Roberts et al., 2009), and the Joint Commission cites an estimated 2.8 million antibiotic-resistant infections and more than 35,000 related deaths each year in the United States (Joint Commission, 2025).

NPG #14 therefore treats stewardship as part of effective medication management: the hospital has an active antibiotic stewardship programme (Joint Commission, 2025). Stewardship is commonly defined as coordinated interventions to improve and measure the appropriate use of antimicrobial agents (Nakamura et al., 2021).

2. History and development

Antimicrobial management teams were evaluated in academic hospitals by 2001, when a team achieved better prescribing than infectious diseases fellows in a setting with a restricted formulary (Gross et al., 2001). In 2009 cost studies of resistant infections provided the economic argument (Roberts et al., 2009). In 2014 the CDC Core Elements of Hospital Antibiotic Stewardship Programs defined the infrastructure and practices of coordinated programmes (Pollack & Srinivasan, 2014), and a systematic review summarised evidence on inpatient programmes (Wagner et al., 2014).

International surveys (Howard et al., 2015), meta-analyses of stewardship objectives (Karanika et al., 2016; Schuts et al., 2016) and implementation in 47 South African hospitals (Brink et al., 2016) followed in 2015-2016. A global consensus on core elements and checklist items appeared in 2019 (Pulcini et al., 2019). The Joint Commission introduced stewardship requirements in 2017 and revised them in 2023 to align with the CDC Core Elements (Joint Commission, 2025).

Milestones: Antimicrobial Stewardship in Hospitals2001Antimicrobial managementteam evaluated2009Costs of resistantinfections2014CDC Core Elementspublished2016Meta-analyses ofstewardship objectives2017Joint Commissionstewardship standard2019Global consensus coreelements2023Standards aligned withCDC; 96% adoption2025Stewardship in NPG #14
Figure 2. Milestones drawn from the Joint Commission fact sheet and dated corpus records cited in this section. Source: produced by the author from the corpus.

3. Definitions and conceptual schema

Stewardship definitions vary in how much they emphasise the drug, the organisation or the outcome.

SourceYearDisciplineDefinition (paraphrased)Emphasised dimension
Nakamura et al. (2021)2021Infectious diseasesCoordinated interventions to improve and measure the appropriate use of antimicrobial agents.Appropriate use
Ture et al. (2023)2023Intensive careCoordinated interventions to improve and track antibiotic use while offering the best prescription by dose, duration and route.Prescription quality in the ICU
Wunderink et al. (2020)2020Critical careThe right drug at the right time and dose for the right bug for the right duration (working definition).The “rights” of prescribing
Pollack & Srinivasan (2014)2014Public health (CDC)Coordinated multidisciplinary programmes with defined infrastructure and practices to improve antibiotic use and patient care.Programme infrastructure
Joint Commission (2025)2025AccreditationThe hospital has an active antibiotic stewardship programme aligned with the CDC Core Elements.Organisational requirement
Table 1. Definition comparison.

The shared core is coordinated action to improve antimicrobial use. Definitions diverge on scope (antibiotics or all antimicrobials), on the primary aim (individual patient outcome or resistance in the population), and on whether stewardship is a set of interventions or a governed programme.

Conceptual schema: Antimicrobial Stewardship in HospitalsLeadership andaccountabilityPharmacy and ID expertiseActions: audit, restriction,de-escalationTracking and reporting ofuseEducation of prescribersDiagnostics and infectioncontrolAntimicrobial stewardshipcoordinated action to improveantimicrobial use
Figure 3. The shared core of the definitions (centre) and the dimensions on which they diverge (outer boxes). Source: produced by the author from the corpus.

4. Distinguishing neighbouring concepts

Stewardship is related to infection prevention and control, rational drug use, clinical pharmacy and medicines stewardship in other therapeutic areas. Infection control prevents transmission; stewardship optimises prescribing; the two are often combined, for example in ICU programmes that pair restriction with infection control (Asiltürk et al., 2024). Medicines stewardship applies the same programme logic to other drug classes such as anticoagulants (Part 6) (Su et al., 2023).

Neighbouring concepts comparedTargetsprescribingTargetstransmissionProgrammestructureRequired by NPG#14Medicationsafety framingAntimicrobial stewardshipInfection prevention andcontrolRational drug useClinical pharmacy servicesAnticoagulation stewardshipcentral featurepartial or context-dependentnot a defining feature
Figure 4. Distinguishing criteria between the focal concept (first row) and neighbouring concepts. Source: produced by the author from the corpus.

5. Types and classifications

Stewardship interventions are usually classified as restrictive or persuasive, supported by enabling diagnostics.

InterventionDescriptionCorpus evidence
Restriction and pre-authorisationSelected agents require approvalEffective alone, but should be supported by audit and feedback (Sengel et al., 2019)
Prospective audit and feedbackReview of ongoing therapy with recommendationsPharmacist-led audit improved appropriateness in an ICU (Ergen et al., 2026)
De-escalationNarrowing or stopping empirical therapyDefined and promoted in ICU guidance (De Waele et al., 2020)
Rapid diagnosticsRapid identification or PCR panels linked to stewardshipLower costs and length of stay (Perez et al., 2013); better stewardship but no proven cure benefit (Enne et al., 2025)
Allergy de-labellingAssessing reported penicillin allergyIncreased use of preferred beta-lactams (Blumenthal et al., 2017)
Table 2. Stewardship interventions.

Programmes also differ in who leads them: infectious diseases physicians, pharmacists or nurses, with several nurse participation models described in the United Kingdom (Castro-Sánchez et al., 2019).

6. Theoretical frameworks and models

The dominant framework is the core elements model: leadership commitment, accountability, pharmacy expertise, action, tracking, reporting and education (Pollack & Srinivasan, 2014), adapted globally through consensus (Pulcini et al., 2019). The second is the stewardship objectives model, which links specific objectives (guideline-based empirical therapy, de-escalation, switch to oral therapy, therapeutic drug monitoring and others) to outcomes (Schuts et al., 2016).

A third, the value model, frames stewardship as an investment with clinical and economic returns (Nathwani et al., 2019).

7. Themes and bibliometric profile

The eligible subcorpus holds 1,040 records (119 of them reviews) with 21,955 citations in the WoS Core Collection. 22 records appeared in 2000-2010 and 907 in 2016-2026, so most of the evidence is recent (Figure 5). The leading journals are Antibiotics-basel (67), Antimicrobial Stewardship & Healthcare Epidemiology (44), Antimicrobial Resistance and Infection Control (37), Journal of Hospital Infection (37). By author address the most active countries are United States (323), England (107), Australia (70), Canada (61), India (54). The most frequent author keywords are: antimicrobial stewardship, antimicrobial resistance, antibiotic stewardship, antibiotics, antimicrobial stewardship program, antibiotic resistance, stewardship, intensive care unit, hospital, infection control. 65 records (6%) explicitly frame their topic with the term “patient safety”.

Themes include (1) effectiveness and value (Karanika et al., 2016; Nathwani et al., 2019; Schuts et al., 2016); (2) intensive care (Luyt et al., 2014; Mokrani et al., 2023; Ture et al., 2023); (3) rapid diagnostics (Buchan et al., 2020; Darie et al., 2022); (4) low- and middle-income settings (Brink et al., 2016; Harun et al., 2024; Siachalinga et al., 2022); (5) COVID-19 and resistance (Tiri et al., 2020).

Publications per year: Antimicrobial Stewardship in Hospitals02754811082000: 020002001: 12002: 02003: 02004: 02005: 020052006: 22007: 02008: 72009: 62010: 620102011: 142012: 172013: 172014: 302015: 3220152016: 412017: 512018: 502019: 822020: 9420202021: 872022: 1042023: 932024: 1042025: 932026: 1082026Records per publication year (n = 1,040); 2026 is a partial year (lighter bar). 2027 early-access records are omitted.
Figure 5. Annual output of the eligible subcorpus, 2000-2026. Source: produced by the author from the corpus.

8. The situation in Türkiye

Türkiye is unusually well represented: 14 records in the stewardship subcorpus have a Turkish address, most of them from intensive care units. A computerised pre-authorisation programme was effective but needed tailored audit and feedback (Sengel et al., 2019). ICU programmes improved quality of care (Gursoy et al., 2022), and a carbapenem-restricted period combined with infection control yielded cost savings (Asiltürk et al., 2024). Pharmacist-led prospective audit and feedback improved antimicrobial appropriateness (Ergen et al., 2026), and multidisciplinary practice with a clinical pharmacist reduced use of reserve antimicrobials (Pehlivanli et al., 2026). A training hospital concluded that every hospital needs a motivated, multidisciplinary stewardship team (Alp et al., 2021). Turkish authors also contributed to international ICU reviews (Ture et al., 2023).

9. Debates and contradictions in the literature

Axis 1: process gains versus patient outcomes. Meta-analyses show improved prescribing and benefits on several outcomes (Karanika et al., 2016; Schuts et al., 2016), but a systematic review rated the strength of evidence as low and noted that most studies were not designed to detect mortality effects (Wagner et al., 2014). Rapid PCR improved stewardship but did not show non-inferiority for pneumonia cure (Enne et al., 2025).

Axis 2: restriction or persuasion? Restriction works quickly (Sengel et al., 2019), whereas audit and feedback relies on communication and acceptance (Ergen et al., 2026; Nakamura et al., 2021). Many programmes combine both (Mokrani et al., 2023).

Axis 3: is stewardship a medication safety issue? The Joint Commission places it under medication management (Joint Commission, 2025), but only 6% of stewardship records in this corpus use the term “patient safety”; the field frames itself through resistance and infection outcomes (De Waele et al., 2018).

10. Measurement problems

Antimicrobial consumption (defined daily doses or days of therapy), appropriateness, resistance rates, Clostridioides difficile infections, length of stay and costs are the common measures (Malani et al., 2013; Nathwani et al., 2019). Each has limits: consumption does not equal appropriateness, and resistance responds slowly and to infection control as well (Asiltürk et al., 2024).

International surveys found that prospective measurement of well-defined outcomes remains a significant challenge (Howard et al., 2015). Evidence from low- and middle-income settings is growing but study designs often lack the quality features needed for validity (Siachalinga et al., 2022).

11. Research gaps and agenda

The following questions are framed so that they can be answered by empirical studies; each notes the evidence gap it derives from.

  1. Do stewardship programmes reduce mortality in adequately powered studies? (Most studies are not designed for this.)
  2. Which combination of restrictive and persuasive interventions works best in ICUs? (Single-intervention studies dominate.)
  3. Can rapid diagnostics improve clinical cure, not only stewardship metrics? (INHALE did not show non-inferiority.)
  4. How can stewardship evidence from LMIC settings meet validity standards? (Design quality gaps documented.)
  5. What is the medication-safety yield of stewardship, for example prevented adverse drug events? (Rarely measured; framing gap.)
  6. How sustainable are Turkish ICU programmes beyond the study period? (Mostly pre-post, single-centre.)

12. Relevance today and practical implications

To meet NPG #14 a hospital needs a programme that satisfies the CDC Core Elements: named leaders, pharmacist expertise, defined actions such as prospective audit and feedback and pre-authorisation, tracking of use and resistance, regular reporting and prescriber education (Joint Commission, 2025; Pollack & Srinivasan, 2014). In ICUs, combining stewardship with infection control and clinical pharmacists is supported by Turkish experience (Asiltürk et al., 2024; Ergen et al., 2026). Adding medication-safety indicators (for example antimicrobial-related adverse drug events and dosing errors) would close the framing gap.

Summary box

  • NPG #14 requires an active antibiotic stewardship programme aligned with the CDC Core Elements.
  • Stewardship is coordinated action to improve and measure antimicrobial use.
  • Programmes improve prescribing and are associated with lower use, resistance and costs.
  • Evidence on mortality is weak because studies are rarely designed for it.
  • Only 6% of stewardship records use “patient safety” framing.
  • Turkish ICUs provide a growing body of pre-post evidence.

Discussion questions

  1. Why does the Joint Commission place stewardship under medication management?
  2. Compare pre-authorisation with prospective audit and feedback.
  3. Why is antimicrobial consumption an imperfect outcome measure?
  4. What does the INHALE trial teach about surrogate stewardship outcomes?
  5. Application: design a monthly stewardship dashboard for a 20-bed ICU.
  6. Application: propose how a clinical pharmacist could be integrated into an ICU stewardship team in a Turkish hospital.

Further reading

  • Pollack & Srinivasan (2014): the CDC Core Elements in journal form.
  • Schuts et al. (2016): meta-analysis linking stewardship objectives to outcomes.
  • Pulcini et al. (2019): global core elements and checklist.
  • Nathwani et al. (2019): the value case for stewardship.
  • Ergen et al. (2026): recent Turkish evidence on pharmacist-led audit and feedback.

Glossary

TermTurkishShort definition
Antimicrobial stewardshipAntimikrobiyal yönetim (akılcı antibiyotik kullanımı programı)Coordinated action to improve antimicrobial use.
Prospective audit and feedbackİleriye dönük denetim ve geri bildirimReview of ongoing therapy with recommendations to prescribers.
Pre-authorisationÖn onay (kısıtlama)Approval required before selected agents are used.
De-escalationDaraltma (de-eskalasyon)Narrowing or stopping empirical therapy.
Antimicrobial resistanceAntimikrobiyal dirençAbility of microbes to survive drugs that once killed them.
Days of therapyTedavi günüNumber of days a patient receives an antimicrobial.
Core ElementsTemel unsurlarCDC framework of seven programme components.

References

Alp, E. E., Oncul, A., Dalgic, N., Akgun, C., Aktas, E., & Bayraktar, B. (2021). Antibiotic Stewardship Program Experience in a Training and Research Hospital. Medical Bulletin of Sisli Etfal Hospital, 55(2), 253-261. https://doi.org/10.14744/SEMB.2020.96337

Asiltürk, D., Güner, R., Kalem, A. K., Turan, I. O., Hasanoglu, I., Eser, F., Malhan, S., & Kayaaslan, B. (2024). Antibiotic management programme in a tertiary intensive care unit: effects of a carbapenem-restricted period on clinical and laboratory parameters and costs of infections. Journal of Hospital Infection, 148, 87-94. https://doi.org/10.1016/j.jhin.2024.03.006

Blumenthal, K. G., Wickner, P. G., Hurwitz, S., Pricco, N., Nee, A. E., Laskowski, K., Shenoy, E. S., & Walensky, R. P. (2017). Tackling inpatient penicillin allergies: Assessing tools for antimicrobial stewardship. Journal of Allergy and Clinical Immunology, 140(1), 154. https://doi.org/10.1016/j.jaci.2017.02.005

Brink, A. J., Messina, A. P., Feldman, C., Richards, G. A., Becker, P. J., Goff, D. A., Bauer, K. A., Nathwani, D., & Van Den Bergh, D. (2016). Antimicrobial stewardship across 47 South African hospitals: an implementation study. Lancet Infectious Diseases, 16(9), 1017-1025. https://doi.org/10.1016/S1473-3099(16)30012-3

Buchan, B. W., Windham, S., Balada-Llasat, J. M., Leber, A., Harrington, A., Relich, R., Murphy, C., Bard, J. D., Naccache, S., Ronen, S., Hopp, A., Mahmutoglu, D., Faron, M. L., Ledeboer, N. A., Carroll, A., Stone, H., Akerele, O., Everhart, K., Bonwit, A., . . ., & Huang, A. G. L. (2020). Practical Comparison of the BioFire FilmArray Pneumonia Panel to Routine Diagnostic Methods and Potential Impact on Antimicrobial Stewardship in Adult Hospitalized Patients with Lower Respiratory Tract Infections. Journal of Clinical Microbiology, 58(7), e00135-20. https://doi.org/10.1128/JCM.00135-20

Castro-Sánchez, E., Gilchrist, M., Ahmad, R., Courtenay, M., Bosanquet, J., & Holmes, A. H. (2019). Nurse roles in antimicrobial stewardship: lessons from public sectors models of acute care service delivery in the United Kingdom. Antimicrobial Resistance and Infection Control, 8(1), 162. https://doi.org/10.1186/s13756-019-0621-4

Darie, A. M., Khanna, N., Jahn, K., Osthoff, M., Bassetti, S., Osthoff, M., Schumann, D. M., Albrich, W. C., Hirsch, H., Brutsche, M., Grize, L., Tamm, M., & Stolz, D. (2022). Fast multiplex bacterial PCR of bronchoalveolar lavage for antibiotic stewardship in hospitalised patients with pneumonia at risk of Gram-negative bacterial infection (Flagship II): a multicentre, randomised controlled trial. Lancet Respiratory Medicine, 10(9), 877-887. https://doi.org/10.1016/S2213-2600(22)00086-8

De Waele, J. J., Akova, M., Antonelli, M., Canton, R., Carlet, J., De Backer, D., Dimopoulos, G., Garnacho-Montero, J., Kesecioglu, J., Lipman, J., Mer, M., Paiva, J. A., Poljak, M., Roberts, J. A., Rodríguez-Baño, J., Timsit, J. F., Zahar, J. R., & Bassetti, M. (2018). Antimicrobial resistance and antibiotic stewardship programs in the ICU: insistence and persistence in the fight against resistance. A position statement from ESICM/ESCMID/WAAAR round table on multi-drug resistance. Intensive Care Medicine, 44(2), 189-196. https://doi.org/10.1007/s00134-017-5036-1

De Waele, J. J., Schouten, J., Beovic, B., Tabah, A., & Leone, M. (2020). Antimicrobial de-escalation as part of antimicrobial stewardship in intensive care: no simple answers to simple questions-a viewpoint of experts. Intensive Care Medicine, 46(2), 236-244. https://doi.org/10.1007/s00134-019-05871-z

Enne, V. I., Stirling, S., Barber, J. A., High, J., Russell, C., Brealey, D., Dhesi, Z., Colles, A., Singh, S., Parker, R., Peters, M., Cherian, B. P., Riley, P., Dryden, M., Simpson, R., Patel, N., Cassidy, J., Martin, D., Welters, I. D., . . ., & Gant, V. (2025). INHALE WP3, a multicentre, open-label, pragmatic randomised controlled trial assessing the impact of rapid, ICU-based, syndromic PCR, versus standard-of-care on antibiotic stewardship and clinical outcomes in hospital-acquired and ventilator-associated pneumonia. Intensive Care Medicine, 51(2), 272-286. https://doi.org/10.1007/s00134-024-07772-2

Ergen, B., Durmusoglu, L. M., Tunçel, T., Kasapoglu, U. S., Yalçinkaya, E., Ilerler, E. E., Karakurt, S., & Sancar, M. (2026). Impact of Pharmacist-Led Antimicrobial Stewardship on Antibiotic Use in Intensive Care: A Prospective Audit and Feedback Approach. Journal of the American College of Clinical Pharmacy, 9(3), e70192. https://doi.org/10.1002/jac5.70192

Gross, R., Morgan, A. S., Kinky, D. E., Weiner, M., Gibson, G. A., & Fishman, N. O. (2001). Impact of a hospital-based antimicrobial management program on clinical and economic outcomes. Clinical Infectious Diseases, 33(3), 289-295. https://doi.org/10.1086/321880

Gursoy, G., Uzun, O., Metan, G., Yildirim, M., Bahap, M., Demirkan, S. K., Topeli, A., Akinci, S. B., Topcuoglu, M. A., Berker, M., Hazirolan, G., Akova, M., & Unal, S. (2022). Do antimicrobial stewardship programs improve the quality of care in ICU patients diagnosed with infectious diseases following consultation? Experience in a tertiary care hospital. International Journal of Infectious Diseases, 115, 201-207. https://doi.org/10.1016/j.ijid.2021.12.315

Harun, M. G. D., Sumon, S. A., Hasan, I., Akther, F. M., Islam, M. S., & Ul Anwar, M. M. (2024). Barriers, facilitators, perceptions and impact of interventions in implementing antimicrobial stewardship programs in hospitals of low-middle and middle countries: a scoping review. Antimicrobial Resistance and Infection Control, 13(1), 8. https://doi.org/10.1186/s13756-024-01369-6

Howard, P., Pulcini, C., Hara, G. L., West, R. M., Gould, I. M., Harbarth, S., & Nathwani, D. (2015). An international cross-sectional survey of antimicrobial stewardship programmes in hospitals. Journal of Antimicrobial Chemotherapy, 70(4), 1245-1255. https://doi.org/10.1093/jac/dku497

Joint Commission. (2025). Effectively managing medications (National Performance Goal #14) [Fact sheet]. https://digitalassets.jointcommission.org/api/public/content/d0c3745c2d7e494ca5199bd3af2a13bc

Karanika, S., Paudel, S., Grigoras, C., Kalbasi, A., & Mylonakis, E. (2016). Systematic Review and Meta-analysis of Clinical and Economic Outcomes from the Implementation of Hospital-Based Antimicrobial Stewardship Programs. Antimicrobial Agents and Chemotherapy, 60(8), 4840-4852. https://doi.org/10.1128/AAC.00825-16

Luyt, C. E., Bréchot, N., Trouillet, J. L., & Chastre, J. (2014). Antibiotic stewardship in the intensive care unit. Critical Care, 18(5), 480. https://doi.org/10.1186/s13054-014-0480-6

Malani, A. N., Richards, P. G., Kapila, S., Otto, M. H., Czerwinski, J., & Singal, B. (2013). Clinical and economic outcomes from a community hospital’s antimicrobial stewardship program. American Journal of Infection Control, 41(2), 145-148. https://doi.org/10.1016/j.ajic.2012.02.021

Mokrani, D., Chommeloux, J., De Chambrun, M. P., Hékimian, G., & Luyt, C. E. (2023). Antibiotic stewardship in the ICU: time to shift into overdrive. Annals of Intensive Care, 13(1), 39. https://doi.org/10.1186/s13613-023-01134-9

Nakamura, S., Arima, T., Tashiro, R., Yasumizu, S., Aikou, H., Watanabe, E., Nakashima, T., Nagatomo, Y., Kakimoto, I., & Motoya, T. (2021). Impact of an antimicrobial stewardship in a 126-bed community hospital with close communication between pharmacists working on post-prescription audit, ward pharmacists, and the antimicrobial stewardship team. Journal of Pharmaceutical Health Care and Sciences, 7(1), 25. https://doi.org/10.1186/s40780-021-00206-x

Nathwani, D., Varghese, D., Stephens, J., Ansari, W., Martin, S., & Charbonneau, C. (2019). Value of hospital antimicrobial stewardship programs [ASPs]: a systematic review. Antimicrobial Resistance and Infection Control, 8, 35. https://doi.org/10.1186/s13756-019-0471-0

Pehlivanli, A., Yalçin, T. Y., Yesiler, F. I., Sari, N., Sahintürk, H., Azap, K., Zeyneloglu, P., & Basgut, B. (2026). Antimicrobial stewardship practices in the intensive care unit: a pre-post interventional study. Turkish Journal of Intensive Care-turk Yogun Bakim Dergisi, 24(3), 165-172. https://doi.org/10.63729/TJIC.2026.700

Perez, K. K., Olsen, R. J., Musick, W. L., Cernoch, P. L., Davis, J. R., Land, G. A., Peterson, L. E., & Musser, J. M. (2013). Integrating Rapid Pathogen Identification and Antimicrobial Stewardship Significantly Decreases Hospital Costs. Archives of Pathology & Laboratory Medicine, 137(9), 1247-1254. https://doi.org/10.5858/arpa.2012-0651-OA

Pollack, L. A., & Srinivasan, A. (2014). Core Elements of Hospital Antibiotic Stewardship Programs From the Centers for Disease Control and Prevention. Clinical Infectious Diseases, 59, S97-S100. https://doi.org/10.1093/cid/ciu542

Pulcini, C., Binda, F., Lamkang, A. S., Trett, A., Charani, E., Goff, D. A., Harbarth, S., Hinrichsen, S. L., Levy-Hara, G., Mendelson, M., Nathwani, D., Gunturu, R., Singh, S., Srinivasan, A., Thamlikitkul, V., Thursky, K., Vlieghe, E., Wertheim, H., Zeng, M., . . ., & Laxminarayan, R. (2019). Developing core elements and checklist items for global hospital antimicrobial stewardship programmes: a consensus approach. Clinical Microbiology and Infection, 25(1), 20-25. https://doi.org/10.1016/j.cmi.2018.03.033

Roberts, R. R., Hota, B., Ahmad, I., Scott, R. D., Foster, S. D., Abbasi, F., Schabowski, S., Kampe, L. M., Ciavarella, G. G., Supino, M., Naples, J., Cordell, R., Levy, S. B., & Weinstein, R. A. (2009). Hospital and Societal Costs of Antimicrobial-Resistant Infections in a Chicago Teaching Hospital: Implications for Antibiotic Stewardship. Clinical Infectious Diseases, 49(8), 1175-1184. https://doi.org/10.1086/605630

Schuts, E. C., Hulscher, M. E. J. L., Mouton, J. W., Verduin, C. M., Stuart, J. W. T. C., Overdiek, H. W. P. M., Van Der Linden, P. D., Natsch, S., Hertogh, C. M. P. M., Wolfs, T. F. W., Schouten, J. A., Kullberg, B. J., & Prins, J. M. (2016). Current evidence on hospital antimicrobial stewardship objectives: a systematic review and meta-analysis. Lancet Infectious Diseases, 16(7), 847-856. https://doi.org/10.1016/S1473-3099(16)00065-7

Sengel, B. E., Bilgin, H., Bilgin, B., Gidener, T., Saydam, S., Pekmezci, A., Ergönül, ., & Korten, V. (2019). The need for an antibiotic stewardship program in a hospital using a computerized pre-authorization system. International Journal of Infectious Diseases, 82, 40-43. https://doi.org/10.1016/j.ijid.2019.02.044

Siachalinga, L., Mufwambi, W., & Lee, I. H. (2022). Impact of antimicrobial stewardship interventions to improve antibiotic prescribing for hospital inpatients in Africa: a systematic review and meta-analysis. Journal of Hospital Infection, 129, 124-143. https://doi.org/10.1016/j.jhin.2022.07.031

Su, E., Liew, D. F. L., Donnelly, J., & Elliott, R. A. (2023). Medicines stewardship. Australian Prescriber, 46(2), 24-28. https://doi.org/10.18773/austprescr.2023.010

Tiri, B., Sensi, E., Marsiliani, V., Cantarini, M., Priante, G., Vernelli, C., Martella, L. A., Costantini, M., Mariottini, A., Andreani, P., Bruzzone, P., Suadoni, F., Francucci, M., Cirocchi, R., & Cappanera, S. (2020). Antimicrobial Stewardship Program, COVID-19, and Infection Control: Spread of Carbapenem-Resistant Klebsiella Pneumoniae Colonization in ICU COVID-19 Patients. What Did Not Work?. Journal of Clinical Medicine, 9(9), 2744. https://doi.org/10.3390/jcm9092744

Ture, Z., Güner, R., & Alp, E. (2023). Antimicrobial stewardship in the intensive care unit. Journal of Intensive Medicine, 3(3), 244-253. https://doi.org/10.1016/j.jointm.2022.10.001

Wagner, B., Filice, G. A., Drekonja, D., Greer, N., MacDonald, R., Rutks, I., Butler, M., & Wilt, T. J. (2014). Antimicrobial Stewardship Programs in Inpatient Hospital Settings: A Systematic Review. Infection Control and Hospital Epidemiology, 35(10), 1209-1228. https://doi.org/10.1086/678057

Wunderink, R. G., Srinivasan, A., Barie, P. S., Chastre, J., Dela Cruz, C. S., Douglas, I. S., Ecklund, M., Evans, S. E., Evans, S. R., Gerlach, A. T., Hicks, L. A., Howell, M., Hutchinson, M. L., Hyzy, R. C., Kane-Gill, S. L., Lease, E. D., Metersky, M. L., Munro, N., Niederman, M. S., . . ., & Weiss, C. H. (2020). Antibiotic Stewardship in the Intensive Care Unit An Official American Thoracic Society Workshop Report in Collaboration with the AACN, CHEST, CDC, and SCCM. Annals of the American Thoracic Society, 17(5), 531-540. https://doi.org/10.1513/AnnalsATS.202003-188ST

Source verification note

Author names, year, journal and DOI details of the 34 corpus-based citations were generated by code directly from the Web of Science records and checked one to one against the in-text citations; claims were checked at the level of record abstracts, and full texts were not read. The Joint Commission fact sheet was read in full on 16 November 2026. No source outside the corpus and the fact sheet is cited.

AI use statement

Anthropic’s Claude model was used to design and run the Web of Science search, tag and pre-screen records, extract evidence from abstracts, draft the English text and produce the figures. Final decisions, the scientific accuracy of the text and final responsibility rest with the author.

Data and supplementary material

The full list of the 1,040 core records and the 1,040 eligible records for this part (author, year, title, journal, DOI, component flags, “patient safety” layer flag and pre-screening suggestion), the screening log of the 4,936-record series corpus and the citation verification report are provided in the series companion workbook (NPG14_Series_Supplementary.xlsx), available from the author on request. The record list is deliberately kept out of the chapter text.

Cite this page (APA 7)

Kurutkan, M. N. (2026, November 16). Antimicrobial Stewardship in Hospitals: An Introduction (101). The Health Topics. https://healthtopic.org/topics/antimicrobial-stewardship-in-hospitals-an-introduction-101/

Subscribe to the Health Topics Newsletter!

Google reCaptcha: Invalid site key.